C-CAST: Expedited Review Programs in Japan
C-CAST is a mini-video series presented by CMIC Group. As the pioneer and leading CRO in Japan, we provide you with short and useful videos about pharmaceutical and healthcare industry, including educational contents, leader & expert interviews, and more. Watch the video and learn about the market/industry trend, latest regulatory information, and new technologies for your product development in the U.S., Japan, and broader Asia.
There are several effective expedited review programs in Japan. In this session, our expert introduced the process, criteria, and incentives of the following two key programs based on our experience.
- Orphan Drug Designation
- SAKIGAKE Designation – corresponding to Breakthrough Therapy Designation by FDA & PRIME Designation by EMA –
Senior Regulatory Consultant, Consulting Division,
CRO Business, CMIC Group